Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial
- Kristine Ensrud
- , Andrea Lacroix
- , John R. Thompson
- , David D. Thompson
- , Richard Eastell
- , David M. Reid
- , Slobodan Vukicevic
- , Jane Cauley
- , Elizabeth Barrett-Connor
- , Roisin Armstrong
- , Francine Welty
- , Steven Cummings
Research output: Contribution to journal › Article › peer-review
42
Link opens in a new tab
Scopus
citations